Ovarian cancer in situ: a case report

Cover Page

Cite item

Full Text

Abstract

In most cases, ovarian cancer is diagnosed at advanced stages, leading to a poor prognosis. Currently, there is no effective screening for ovarian cancer, so detecting it in the early stages is a fairly successful case.

About the authors

A. N. Turomsha

AVA-PETER LLC

Author for correspondence.
Email: turomsha-an@avaclinic.ru
ORCID iD: 0009-0008-4164-2372

Alesya Nikolaevna Turomsha

Build. 2, 4 Ilyushina St., Saint Petersburg 196634

Russian Federation

A. E. Protasova

AVA-PETER LLC; Saint Petersburg State University; V.A. Almazov National Medical Research Centre, Ministry of Health of Russia

ORCID iD: 0000-0001-7930-8048

Build. 2, 4 Ilyushina St., Saint Petersburg 196634; 7—9 Universitetskaya Naberezhnaya, Saint Petersburg 199034; 2 Akkuratova St., Saint Petersburg 197341

Russian Federation

G. A. Raskin

Saint Petersburg State University; Medical Diagnostic Center, Medical Institute named after Berezin Sergey

7—9 Universitetskaya Naberezhnaya, Saint Petersburg 199034; Build. 3A, 2 Yesenina St., Saint Petersburg 194354

Russian Federation

E. D. Kravtsova

Medical Diagnostic Center, Medical Institute named after Berezin Sergey

Build. 3A, 2 Yesenina St., Saint Petersburg 194354

Russian Federation

A. L. Andreev

AVA-PETER LLC

Build. 2, 4 Ilyushina St., Saint Petersburg 196634

Russian Federation

L. V. Strakh

AVA-PETER LLC

ORCID iD: 0000-0001-5943-1081

Build. 2, 4 Ilyushina St., Saint Petersburg 196634

Russian Federation

M. Yu. Sheremet

AVA-PETER LLC

ORCID iD: 0009-0008-4392-0700

Build. 2, 4 Ilyushina St., Saint Petersburg 196634

Russian Federation

References

  1. Situtation with cancer care in Russia in 2021. Ed. by A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: P.A. Herzen Moscow Oncology Research Institute - a branch of the National Medical Research Radiological Center, Ministry of Health of Russia, 2022. 239 p. (In Russ.).
  2. National Cancer Institute SEER Program. Cancer Stat Facts: Ovarian Cancer. Available at: https://seer.cancer.gov/statfacts/html/ovary.html.
  3. ACOG Committee Opinion No. 755: Well-Woman Visit. Obstet Gynecol 2018;132(4):e181-6. doi: 10.1097/AOG.0000000000002897
  4. Andrews L., Mutch D.G. Hereditary ovarian cancer and risk reduction. Best Pract Res Clin Obstet Gynaecol 2017;41:31-48. doi: 10.1016/j.bpobgyn.2016.10.017
  5. Daly M.B., Pal T., Berry M.P. et al. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20216;19(1):77-102. doi: 10.6004/jnccn.2021.0001
  6. Gonzalez-Martm A., Harter P., Leary A. et al. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2023;34(10):833-48. doi: 10.1016/j.annonc.2023.07.011
  7. Frank G.A., Moskvina L.V., Andreeva Yu.Yu. A new classification of ovarian tumors. Arkhiv Patologii = Pathology Archive 2015;77(4):40-50. (In Russ.). doi: 10.17116/patol201577440-50
  8. WHO Classification of Tumours Editorial Board. Female Genital Tumours. 5th edn. Lyon: International Agency for Research on Cancer, 2020. Available at: https://tumourclassification.iarc.who.int.
  9. Babaier A., Ghatage P. Mucinous cancer of the ovary: Overview and current status. Diagnostics (Basel) 2020;10(1):52. doi: 10.3390/diagnostics10010052
  10. Inoue K., Tsubamoto H., Hao H. et al. Ovarian carcinoma in situ of presumable fallopian tube origin in a patient with Lynch syndrome: A case report. Gynecol Oncol Case Rep 2013;5:61-3. doi: 10.1016/j.gynor.2013.05.002

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36991 от  21.07.2009.